CN204072201U - 组装夹具和植入物 - Google Patents
组装夹具和植入物 Download PDFInfo
- Publication number
- CN204072201U CN204072201U CN201420118276.5U CN201420118276U CN204072201U CN 204072201 U CN204072201 U CN 204072201U CN 201420118276 U CN201420118276 U CN 201420118276U CN 204072201 U CN204072201 U CN 204072201U
- Authority
- CN
- China
- Prior art keywords
- rib
- pillar
- implant
- eptfe
- platen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000007943 implant Substances 0.000 title claims abstract description 42
- 229920000642 polymer Polymers 0.000 claims abstract description 26
- 238000000465 moulding Methods 0.000 claims abstract description 21
- 230000002093 peripheral effect Effects 0.000 claims abstract description 16
- 230000009467 reduction Effects 0.000 claims abstract description 12
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims description 100
- 238000004873 anchoring Methods 0.000 claims description 17
- 238000005452 bending Methods 0.000 claims description 11
- 230000015572 biosynthetic process Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 abstract description 48
- 238000000926 separation method Methods 0.000 abstract description 43
- 238000004519 manufacturing process Methods 0.000 abstract description 14
- 238000010438 heat treatment Methods 0.000 abstract description 13
- 229920000573 polyethylene Polymers 0.000 description 74
- 239000000463 material Substances 0.000 description 70
- -1 polyethylene Polymers 0.000 description 59
- 239000004698 Polyethylene Substances 0.000 description 57
- 229920001169 thermoplastic Polymers 0.000 description 52
- 239000004416 thermosoftening plastic Substances 0.000 description 52
- 238000005192 partition Methods 0.000 description 30
- 210000002216 heart Anatomy 0.000 description 27
- 239000002356 single layer Substances 0.000 description 24
- 239000004744 fabric Substances 0.000 description 19
- 238000003475 lamination Methods 0.000 description 16
- 239000010410 layer Substances 0.000 description 14
- 238000003825 pressing Methods 0.000 description 14
- 238000005538 encapsulation Methods 0.000 description 13
- 239000012530 fluid Substances 0.000 description 13
- 210000005240 left ventricle Anatomy 0.000 description 13
- 230000008569 process Effects 0.000 description 12
- 206010019280 Heart failures Diseases 0.000 description 11
- 230000004927 fusion Effects 0.000 description 11
- 206010007559 Cardiac failure congestive Diseases 0.000 description 10
- 229910052751 metal Inorganic materials 0.000 description 10
- 239000002184 metal Substances 0.000 description 10
- 238000001816 cooling Methods 0.000 description 9
- 239000003826 tablet Substances 0.000 description 9
- 239000002775 capsule Substances 0.000 description 8
- 239000008280 blood Substances 0.000 description 7
- 210000004369 blood Anatomy 0.000 description 7
- 238000010586 diagram Methods 0.000 description 7
- 239000000835 fiber Substances 0.000 description 7
- 239000012528 membrane Substances 0.000 description 7
- 230000000295 complement effect Effects 0.000 description 6
- 238000000354 decomposition reaction Methods 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- 229920001903 high density polyethylene Polymers 0.000 description 6
- 239000004700 high-density polyethylene Substances 0.000 description 6
- 239000011159 matrix material Substances 0.000 description 6
- 238000004804 winding Methods 0.000 description 6
- 229950000845 politef Drugs 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 238000009954 braiding Methods 0.000 description 4
- 210000005242 cardiac chamber Anatomy 0.000 description 4
- 230000008021 deposition Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 230000008595 infiltration Effects 0.000 description 4
- 238000001764 infiltration Methods 0.000 description 4
- 238000010030 laminating Methods 0.000 description 4
- 238000002844 melting Methods 0.000 description 4
- 230000008018 melting Effects 0.000 description 4
- 239000002861 polymer material Substances 0.000 description 4
- 239000012815 thermoplastic material Substances 0.000 description 4
- 230000002861 ventricular Effects 0.000 description 4
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 208000019622 heart disease Diseases 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229910001000 nickel titanium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000007493 shaping process Methods 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000020446 Cardiac disease Diseases 0.000 description 2
- 208000006029 Cardiomegaly Diseases 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 239000000560 biocompatible material Substances 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 238000006073 displacement reaction Methods 0.000 description 2
- 230000002349 favourable effect Effects 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 238000007710 freezing Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000000149 penetrating effect Effects 0.000 description 2
- 238000001050 pharmacotherapy Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 238000005086 pumping Methods 0.000 description 2
- 238000007789 sealing Methods 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 230000008023 solidification Effects 0.000 description 2
- 230000008093 supporting effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000002054 transplantation Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 206010033372 Pain and discomfort Diseases 0.000 description 1
- 101150034459 Parpbp gene Proteins 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 229910052797 bismuth Inorganic materials 0.000 description 1
- JCXGWMGPZLAOME-UHFFFAOYSA-N bismuth atom Chemical compound [Bi] JCXGWMGPZLAOME-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000032798 delamination Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000000025 haemostatic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 238000007914 intraventricular administration Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- GKOZUEZYRPOHIO-UHFFFAOYSA-N iridium atom Chemical compound [Ir] GKOZUEZYRPOHIO-UHFFFAOYSA-N 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000005246 left atrium Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 210000004115 mitral valve Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 230000036316 preload Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 229910052703 rhodium Inorganic materials 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- MHOVAHRLVXNVSD-UHFFFAOYSA-N rhodium atom Chemical compound [Rh] MHOVAHRLVXNVSD-UHFFFAOYSA-N 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 229910052715 tantalum Inorganic materials 0.000 description 1
- GUVRBAGPIYLISA-UHFFFAOYSA-N tantalum atom Chemical compound [Ta] GUVRBAGPIYLISA-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000003856 thermoforming Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- WFKWXMTUELFFGS-UHFFFAOYSA-N tungsten Chemical compound [W] WFKWXMTUELFFGS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 239000010937 tungsten Substances 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12099—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder
- A61B17/12122—Occluding by internal devices, e.g. balloons or releasable wires characterised by the location of the occluder within the heart
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/12—Surgical instruments, devices or methods for ligaturing or otherwise compressing tubular parts of the body, e.g. blood vessels or umbilical cord
- A61B17/12022—Occluding by internal devices, e.g. balloons or releasable wires
- A61B17/12131—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device
- A61B17/12168—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure
- A61B17/12172—Occluding by internal devices, e.g. balloons or releasable wires characterised by the type of occluding device having a mesh structure having a pre-set deployed three-dimensional shape
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00526—Methods of manufacturing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B2017/00831—Material properties
- A61B2017/00955—Material properties thermoplastic
Landscapes
- Health & Medical Sciences (AREA)
- Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Reproductive Health (AREA)
- Medical Informatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Prostheses (AREA)
- External Artificial Organs (AREA)
- Surgical Instruments (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/827,927 US9332992B2 (en) | 2004-08-05 | 2013-03-14 | Method for making a laminar ventricular partitioning device |
| US13/827,927 | 2013-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN204072201U true CN204072201U (zh) | 2015-01-07 |
Family
ID=50442723
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201420118276.5U Expired - Fee Related CN204072201U (zh) | 2013-03-14 | 2014-03-14 | 组装夹具和植入物 |
| CN201410097592.3A Expired - Fee Related CN104042300B (zh) | 2013-03-14 | 2014-03-14 | 用于制造层状心室分隔设备的系统和方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410097592.3A Expired - Fee Related CN104042300B (zh) | 2013-03-14 | 2014-03-14 | 用于制造层状心室分隔设备的系统和方法 |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2967570A2 (enExample) |
| JP (1) | JP2016512141A (enExample) |
| KR (2) | KR101713607B1 (enExample) |
| CN (2) | CN204072201U (enExample) |
| AU (1) | AU2014239608A1 (enExample) |
| BR (1) | BR112015021613A2 (enExample) |
| CA (1) | CA2901532A1 (enExample) |
| IL (1) | IL240520A0 (enExample) |
| RU (1) | RU2015143955A (enExample) |
| WO (1) | WO2014152461A2 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104706444A (zh) * | 2015-03-03 | 2015-06-17 | 上海形状记忆合金材料有限公司 | 左心室减容装置 |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3197397B1 (en) * | 2014-09-28 | 2021-01-13 | Cardiokinetix, Inc. | Apparatuses for treating cardiac dysfunction |
| CN105476733B (zh) * | 2016-01-27 | 2017-09-01 | 张刚成 | 心脏减容装置 |
| CN106073947A (zh) * | 2016-08-29 | 2016-11-09 | 关丽鹃 | 心脏减容系统 |
| US20200029849A1 (en) * | 2016-09-29 | 2020-01-30 | Innervate Medical, Llc | Uses of minimally invasive systems and methods for neurovascular signal management including endovascular electroencephalography and related techniques for epilepsy detection and treatment |
| CN110612073B (zh) * | 2017-01-05 | 2022-06-07 | 和谐发展集团有限公司 | 用于捕获反流射流、体积及力以实现心室功能及重塑的可扩张装置 |
| WO2019006152A1 (en) | 2017-06-28 | 2019-01-03 | Harmony Development Group, Inc. | INFLATABLE TRANSDUCTION IMPLANT SYSTEM COMPRISING AN ANNULAR DOUBLE FORCE TRANSDUCTION IMPLANT |
| US11167122B2 (en) | 2018-03-05 | 2021-11-09 | Harmony Development Group, Inc. | Force transducting implant system for the mitigation of atrioventricular pressure gradient loss and the restoration of healthy ventricular geometry |
| CN109820551B (zh) * | 2019-02-22 | 2022-03-01 | 北京大学深圳研究生院 | 一种充气式心室隔离装置 |
| CN110974349B (zh) * | 2019-11-25 | 2022-08-02 | 湖南瑞康通科技发展有限公司 | 取栓装置及取栓组件 |
| US20240216098A1 (en) * | 2022-12-28 | 2024-07-04 | Coherex Medical, Inc. | Cover for medical device, system and method thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20100030256A1 (en) * | 1997-11-12 | 2010-02-04 | Genesis Technologies Llc | Medical Devices and Methods |
| US7128073B1 (en) * | 1998-11-06 | 2006-10-31 | Ev3 Endovascular, Inc. | Method and device for left atrial appendage occlusion |
| US8257428B2 (en) * | 1999-08-09 | 2012-09-04 | Cardiokinetix, Inc. | System for improving cardiac function |
| US8529430B2 (en) * | 2002-08-01 | 2013-09-10 | Cardiokinetix, Inc. | Therapeutic methods and devices following myocardial infarction |
| US20060030881A1 (en) * | 2004-08-05 | 2006-02-09 | Cardiokinetix, Inc. | Ventricular partitioning device |
| US20060106420A1 (en) * | 2004-11-12 | 2006-05-18 | Medtronic Vascular, Inc. | Patch for treating a septal defect |
| US9545300B2 (en) * | 2004-12-22 | 2017-01-17 | W. L. Gore & Associates, Inc. | Filament-wound implantable devices |
| CA2687743A1 (en) * | 2007-05-31 | 2008-12-11 | Rex Medical, L.P. | Closure device for left atrial appendage |
| US9414842B2 (en) * | 2007-10-12 | 2016-08-16 | St. Jude Medical, Cardiology Division, Inc. | Multi-component vascular device |
| WO2010081039A1 (en) * | 2009-01-08 | 2010-07-15 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
| AU2009344181A1 (en) * | 2009-04-10 | 2011-10-13 | Cardiokinetix, Inc. | Sealing and filling ventricular partitioning devices to improve cardiac function |
| US9883864B2 (en) * | 2009-06-17 | 2018-02-06 | Coherex Medical, Inc. | Medical device for modification of left atrial appendage and related systems and methods |
| US20110054515A1 (en) * | 2009-08-25 | 2011-03-03 | John Bridgeman | Device and method for occluding the left atrial appendage |
| JP5875986B2 (ja) * | 2009-10-26 | 2016-03-02 | カーディオキネティックス・インコーポレイテッドＣａｒｄｉｏｋｉｎｅｔｉｘ， Ｉｎｃ． | 心室容積縮小 |
| KR101070811B1 (ko) * | 2011-02-18 | 2011-10-06 | 강원대학교산학협력단 | 심실구획장치 |
-
2014
- 2014-03-14 WO PCT/US2014/027364 patent/WO2014152461A2/en not_active Ceased
- 2014-03-14 KR KR1020157028718A patent/KR101713607B1/ko not_active Expired - Fee Related
- 2014-03-14 AU AU2014239608A patent/AU2014239608A1/en not_active Abandoned
- 2014-03-14 CN CN201420118276.5U patent/CN204072201U/zh not_active Expired - Fee Related
- 2014-03-14 KR KR1020177005196A patent/KR20170024147A/ko not_active Withdrawn
- 2014-03-14 JP JP2016502416A patent/JP2016512141A/ja active Pending
- 2014-03-14 BR BR112015021613A patent/BR112015021613A2/pt not_active IP Right Cessation
- 2014-03-14 CA CA2901532A patent/CA2901532A1/en not_active Abandoned
- 2014-03-14 RU RU2015143955A patent/RU2015143955A/ru not_active Application Discontinuation
- 2014-03-14 CN CN201410097592.3A patent/CN104042300B/zh not_active Expired - Fee Related
- 2014-03-14 EP EP14716179.8A patent/EP2967570A2/en not_active Withdrawn
-
2015
- 2015-08-12 IL IL240520A patent/IL240520A0/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104706444A (zh) * | 2015-03-03 | 2015-06-17 | 上海形状记忆合金材料有限公司 | 左心室减容装置 |
Also Published As
| Publication number | Publication date |
|---|---|
| IL240520A0 (en) | 2015-10-29 |
| CN104042300B (zh) | 2017-11-28 |
| CN104042300A (zh) | 2014-09-17 |
| WO2014152461A3 (en) | 2014-12-04 |
| KR20170024147A (ko) | 2017-03-06 |
| KR20150127242A (ko) | 2015-11-16 |
| RU2015143955A (ru) | 2017-04-20 |
| AU2014239608A1 (en) | 2015-08-27 |
| EP2967570A2 (en) | 2016-01-20 |
| BR112015021613A2 (pt) | 2017-07-18 |
| KR101713607B1 (ko) | 2017-03-09 |
| JP2016512141A (ja) | 2016-04-25 |
| WO2014152461A2 (en) | 2014-09-25 |
| CA2901532A1 (en) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN204072201U (zh) | 组装夹具和植入物 | |
| US7897086B2 (en) | Method of making a laminar ventricular partitioning device | |
| US9332992B2 (en) | Method for making a laminar ventricular partitioning device | |
| US11813386B2 (en) | Interatrial shunt with expanded neck region | |
| EP4129210B1 (en) | Method of obtaining a left atrial appendage occluder device | |
| CA2955389C (en) | Devices and methods for treating heart failure | |
| EP2819585B1 (en) | A device for occluding an opening in a body and associated methods | |
| US10064696B2 (en) | Devices and methods for delivering an endocardial device | |
| US20050015140A1 (en) | Encapsulation device and methods of use | |
| US20120010697A1 (en) | Heart valve prosthesis using different types of living tissue and method of fabricating the same | |
| CN204909516U (zh) | 行进通过患者的脉管系统的系统及对患者的心腔执行外科手术的套件 | |
| CN104039246A (zh) | 可膨胀的闭塞装置及使用方法 | |
| CN106539605A (zh) | 植入物和操作植入物组件的方法 | |
| CN109963531A (zh) | 用于治疗血管和非血管疾病的导管系统 | |
| CN103179909A (zh) | 用于闭合血管中的开口或空腔的装置 | |
| CN107889455A (zh) | 生物相容性生物医学闭塞装置 | |
| WO2016073568A1 (en) | Percutaneous implantable nuclear prosthesis | |
| CN109745094A (zh) | 封堵装置 | |
| CN101185582A (zh) | 机械组织装置及方法 | |
| CN114269261A (zh) | 医疗植入物和用于医疗植入物的递送装置 | |
| MXPA01004564A (en) | Method and device for left atrial appendage occlusion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150107 |